GlaxoSmithKline Pharma March quarter net at Rs 106 cr

GlaxoSmithKline Pharmaceuticals today reported a standalone net profit of Rs 105.98 crore for the quarter ended March 31, 2016.
The company had posted a net profit of Rs 102.85 crore for the same period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a filing to BSE.
Standalone total income from operations of the company stood at Rs 692.97 crore for the quarter under consideration. It was Rs 618.06 crore for the year ago period.
For 2015-16 fiscal, the company posted a net profit of Rs 375.21 crore. It was Rs 471.65 crore for the fifteen months ended March 31, 2015.

Standalone total income from operations of the company was at Rs 2,756.96 for the fiscal ended March 31, 2016. It was Rs 3,287.58 crore for the fifteen months ended March 2015.
The accounting year of the company has been changed from January-December to April-March with effect from the previous period. Consequently, the previous financial statements are for the 15 months from January 1,2014 to March 31, 2015, GlaxoSmithKline Pharmaceuticals said.

"In view of this, the current year's figures are not comparable with those of the previous period," it added.
In a separate filing the company said its board has recommended a dividend of 500 per cent on the equity share capital i.E. Rs 50 per equity share for the year ended March 31, 2016.

Shares of GlaxoSmithKline Pharmaceuticals today closed at Rs 3,425.30 per scrip on BSE, up 0.95 per cent from its previous close.